CompletedNot Applicable

Reiki Therapy to Improve Key Symptoms in Integrative Oncology Clinic (REIKI)

United States10 participantsStarted 2024-08-07

Plain-language summary

The purpose of this research is to investigate the delivery of Reiki to integrative oncology patients and assess its potential for improving cancer-related symptoms in this population.

Who can participate

Age range

18 Years – 89 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 - 89. * Neoplasm diagnosis (i.e., ICD-10 C00 - D49) confirmed in electronic health record (EHR)/Caisis * Receiving care at a UH Connor Whole Health Integrative Oncology Clinic. * Reporting at least three ESAS symptoms ≥4/10 at baseline screening including fatigue and ≥2 other symptoms on the 9-item questionnaire. * Able to speak and understand English. * Has an email address, and access to a computer with internet and/or a mobile device with a functioning data plan Exclusion Criteria: * Significant cognitive impairment that has not been corrected. * Significant visual impairment that has not been corrected. * Unable to provide informed consent. * Active psychosis. * Pregnancy. * Metastatic disease. * Reiki therapy within 3 months of study enrollment * Active immunotherapy, chemotherapy, or radiation treatment, or completed within 3 months before study start. Aromatase inhibitors and tamoxifen are exceptions.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Recruitment rate as measured by the percentage of participants enrolled

Timeframe: 8 weeks post enrollment

Retention rate as measured by the number of participants retained until the final survey point

Timeframe: 8 weeks post enrollment

Attendance rate as measured by number of sessions attended per 6 sessions

Timeframe: 8 weeks post enrollment

Protocol adherence rate as measured by the number of participants treated in manner consistent with the intervention

Timeframe: 8 weeks post enrollment

Acceptability as measured by the patient mean of participant satisfaction survey

Timeframe: 8 weeks post enrollment

Data completeness rate

Timeframe: 8 weeks post enrollment

Trial details

NCT IDNCT06354049

SponsorCase Comprehensive Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-17

View on ClinicalTrials.gov More Cancer Pain trials

Who can participate

Age range

18 Years – 89 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Recruitment rate as measured by the percentage of participants enrolled

Timeframe: 8 weeks post enrollment

Retention rate as measured by the number of participants retained until the final survey point

Timeframe: 8 weeks post enrollment

Attendance rate as measured by number of sessions attended per 6 sessions

Timeframe: 8 weeks post enrollment

Protocol adherence rate as measured by the number of participants treated in manner consistent with the intervention

Timeframe: 8 weeks post enrollment

Acceptability as measured by the patient mean of participant satisfaction survey

Timeframe: 8 weeks post enrollment

Data completeness rate

Timeframe: 8 weeks post enrollment